Critical roles of RasGRP1 for invariant NKT cell development

Journal of Immunology

Volumn 187, Issue 9, 2011, Pages 4467-4473

  Shen, Shudan ^a   Chen, Yong ^a,b   Gorentla, Balachandra K ^a   Lu, Jianxin ^b   Stone, James C ^c   Zhong, Xiao Ping ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; RAS PROTEIN; RASGRP1 PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INVARIANT NATURAL KILLER CELL; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THYMOCYTE;

ANIMALS; ANTIGENS, CD4; CELL DIFFERENTIATION; CELL LINEAGE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION;

EID: 80555133366     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003798     Document Type: Article

References (50)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336. (Pubitemid 46697911)
2. Matsuda, J. L., T. Mallevaey, J. Scott-Browne, and L. Gapin. 2008. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr. Opin. Immunol. 20: 358-368.
3. Cerundolo, V., and M. Kronenberg. 2010. The role of invariant NKT cells at the interface of innate and adaptive immunity. Semin. Immunol. 22: 59-60.
4. Godfrey, D. I., S. Stankovic, and A. G. Baxter. 2010. Raising the NKT cell family. Nat. Immunol. 11: 197-206.
5. Van Kaer, L. 2007. NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19: 354-364. (Pubitemid 46687006)
6. Zhou, D., J. Mattner, C. Cantu, III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789. (Pubitemid 39601398)
7. Gapin, L., J. L. Matsuda, C. D. Surh, and M. Kronenberg. 2001. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat. Immunol. 2: 971-978. (Pubitemid 32976171)
8. Benlagha, K., D. G. Wei, J. Veiga, L. Teyton, and A. Bendelac. 2005. Characterization of the early stages of thymic NKT cell development. J. Exp. Med. 202: 485-492. (Pubitemid 41186947)
9. (+) CD1d-dependent precursor stage. J. Exp. Med. 195: 835-844.
10. - NKT cell population. Proc. Natl. Acad. Sci. USA 105: 11287-11292.
11. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCRmediated activation of Vα14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
12. Mendiratta, S. K., W. D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477. (Pubitemid 27208202)
13. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL- 12-mediated rejection of tumors. Science 278: 1623-1626. (Pubitemid 27516281)
14. Zhong, X. P., R. Guo, H. Zhou, C. Liu, and C. K. Wan. 2008. Diacylglycerol kinases in immune cell function and self-tolerance. Immunol. Rev. 224: 249-264.
15. Lazarevic, V., A. J. Zullo, M. N. Schweitzer, T. L. Staton, E. M. Gallo, G. R. Crabtree, and L. H. Glimcher. 2009. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 10: 306-313.
16. Stanic, A. K., J. S. Bezbradica, J. J. Park, N. Matsuki, A. L. Mora, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. NF-kB controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes. J. Immunol. 172: 2265-2273. (Pubitemid 38182374)
17. Stanic, A. K., J. S. Bezbradica, J. J. Park, L. Van Kaer, M. R. Boothby, and S. Joyce. 2004. Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. J. Immunol. 172: 4667-4671. (Pubitemid 38456384)
18. + regulatory and natural killer-like T cells on signals leading to NFkappaB activation. Proc. Natl. Acad. Sci. USA 101: 4566-4571.
19. Elewaut, D., R. B. Shaikh, K. J. Hammond, H. De Winter, A. J. Leishman, S. Sidobre, O. Turovskaya, T. I. Prigozy, L. Ma, T. A. Banks, et al. 2003. NIKdependent RelB activation defines a unique signaling pathway for the development of Vα14i NKT cells. J. Exp. Med. 197: 1623-1633. (Pubitemid 36745338)
20. + transition as well as IL-15-induced expansion of NKT cells. Eur. J. Immunol. 38: 3508-3519.
21. Sivakumar, V., K. J. Hammond, N. Howells, K. Pfeffer, and F. Weih. 2003. Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J. Exp. Med. 197: 1613-1621. (Pubitemid 36745337)
22. Dower, N. A., S. L. Stang, D. A. Bottorff, J. O. Ebinu, P. Dickie, H. L. Ostergaard, and J. C. Stone. 2000. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nat. Immunol. 1: 317-321.
23. Priatel, J. J., S. J. Teh, N. A. Dower, J. C. Stone, and H. S. Teh. 2002. RasGRP1 transduces low-grade TCR signals which are critical for T cell development, homeostasis, and differentiation. Immunity 17: 617-627. (Pubitemid 35351507)
24. Shen, S., J. Wu, S. Srivatsan, B. K. Gorentla, J. Shin, L. Xu, and X. P. Zhong. Tight regulation of diacylglycerol-mediated signaling is critical for proper invariant NKT cell development. J. Immunol. 187: 2122-2129.
25. Zhong, X. P., E. A. Hainey, B. A. Olenchock, M. S. Jordan, J. S. Maltzman, K. E. Nichols, H. Shen, and G. A. Koretzky. 2003. Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat. Immunol. 4: 882-890. (Pubitemid 37098659)
26. Wei, D. G., H. Lee, S. H. Park, L. Beaudoin, L. Teyton, A. Lehuen, and A. Bendelac. 2005. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J. Exp. Med. 202: 239-248. (Pubitemid 41043820)
27. + T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182: 2091-2096.
28. D'Cruz, L. M., J. Knell, J. K. Fujimoto, and A. W. Goldrath. 2010. An essential role for the transcription factor HEB in thymocyte survival, Tcra rearrangement and the development of natural killer T cells. Nat. Immunol. 11: 240-249.
29. + stage of thymic ontogeny. Proc. Natl. Acad. Sci. USA 102: 5114-5119.
30. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762. (Pubitemid 350102258)
31. Pasquier, B., L. Yin, M. C. Fondanèche, F. Relouzat, C. Bloch-Queyrat, N. Lambert, A. Fischer, G. de Saint-Basile, and S. Latour. 2005. Defective NKT cell development in mice and humans lacking the adapter SAP, the Xlinked lymphoproliferative syndrome gene product. J. Exp. Med. 201: 695-701. (Pubitemid 40395115)
32. Nichols, K. E., J. Hom, S. Y. Gong, A. Ganguly, C. S. Ma, J. L. Cannons, S. G. Tangye, P. L. Schwartzberg, G. A. Koretzky, and P. L. Stein. 2005. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11: 340-345. (Pubitemid 40460564)
33. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163: 4091-4094. (Pubitemid 29474468)
34. Gadue, P., N. Morton, and P. L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190: 1189-1196.
35. Egawa, T., G. Eberl, I. Taniuchi, K. Benlagha, F. Geissmann, L. Hennighausen, A. Bendelac, and D. R. Littman. 2005. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity 22: 705-716. (Pubitemid 40814501)
36. Mycko, M. P., I. Ferrero, A. Wilson, W. Jiang, T. Bianchi, A. Trumpp, and H. R. MacDonald. 2009. Selective requirement for c-Myc at an early stage of V (a)14i NKT cell development. J. Immunol. 182: 4641-4648.
37. Das, R., D. B. Sant'Angelo, and K. E. Nichols. 2010. Transcriptional control of invariant NKT cell development. Immunol. Rev. 238: 195-215.
38. Kovalovsky, D., O. U. Uche, S. Eladad, R. M. Hobbs,W. Yi, E. Alonzo, K. Chua, M. Eidson, H. J. Kim, J. S. Im, et al. 2008. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9: 1055-1064.
39. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
40. Gumperz, J. E., S. Miyake, T. Yamamura, and M. B. Brenner. 2002. Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. J. Exp. Med. 195: 625-636. (Pubitemid 34461507)
41. Lee, P. T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional lineages of human V(α)24 natural killer T cells. J. Exp. Med. 195: 637-641. (Pubitemid 34461508)
42. Priatel, J. J., X. Chen, Y. H. Huang, M. T. Chow, L. A. Zenewicz, J. J. Coughlin, H. Shen, J. C. Stone, R. Tan, and H. S. Teh. 2010. RasGRP1 regulates antigeninduced developmental programming by naive CD8 T cells. J. Immunol. 184: 666-676.
43. Chen, X., J. J. Priatel, M. T. Chow, and H. S. Teh. 2008. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice. J. Immunol. 180: 5973-5982.
44. Gorentla, B. K., C. K. Wan, and X. P. Zhong. 2011. Negative regulation of mTOR activation by diacylglycerol kinases. Blood 117: 4022-4031.
45. Zhong, X. P., J. Shin, B. K. Gorentla, T. O'Brien, S. Srivatsan, L. Xu, Y. Chen, D. Xie, and H. Pan. 2011. Receptor signaling in immune cell development and function. Immunol. Res. 49: 109-123.
46. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129: 1261-1274. (Pubitemid 46962095)
47. Sarbassov, D. D., S. M. Ali, and D. M. Sabatini. 2005. Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17: 596-603. (Pubitemid 41540408)
48. Roose, J. P., M. Mollenauer, M. Ho, T. Kurosaki, and A. Weiss. 2007. Unusual interplay of two types of Ras activators, RasGRP and SOS, establishes sensitive and robust Ras activation in lymphocytes. Mol. Cell. Biol. 27: 2732-2745. (Pubitemid 46581361)
49. Kim, P. J., S. Y. Pai, M. Brigl, G. S. Besra, J. Gumperz, and I. C. Ho. 2006. GATA-3 regulates the development and function of invariant NKT cells. J. Immunol. 177: 6650-6659. (Pubitemid 44715028)
50. Alberola-Ila, J., K. A. Hogquist, K. A. Swan, M. J. Bevan, and R. M. Perlmutter. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184: 9-18.